| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.003 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.004 |
| mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |